tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CLSD is currently covered by 4 analysts
Clearside Biomedical's activity chart (see below) currently has 73 price targets and 86 ratings on display. The stock rating distribution of CLSD is 71.43% BUY and 28.57% HOLD.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 819.3 days.
Highest price target for CLSD is $15, Lowest price target is $3.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 17-Nov-2025. First documented stock forecast 14-Aug-2016.
Currently out of the existing stock ratings of CLSD, 10 are a BUY (71.43%), 4 are a HOLD (28.57%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$3
8 months 17 days ago
(17-Nov-2025)
15/15 (100%)
$-6.03 (-66.78%)
450
Hold
$5
$2.28 (83.82%)
$5
1 years 17 days ago
(17-Jul-2025)
20/20 (100%)
$-1.14 (-18.57%)
557
Hold
$6
1 years 17 days ago
(17-Jul-2025)
3/3 (100%)
$-8.25 (-57.89%)
243
Buy
$5
$2.28 (83.82%)
$5
1 years 2 months 19 days ago
(15-May-2025)
9/9 (100%)
$-8.18 (-62.06%)
686
Buy
$5
$2.28 (83.82%)
$5
2 years 1 months 10 days ago
(24-Jun-2024)
2/2 (100%)
$-13.75 (-73.33%)
494
What is CLSD (Clearside Biomedical) average time for price targets to be met?
Which analyst has the current highest performing score on CLSD (Clearside Biomedical) with a proven track record?
Which analyst has the most public recommendations on CLSD (Clearside Biomedical)?
Which analyst is the currently most bullish on CLSD (Clearside Biomedical)?
Which analyst is the currently most reserved on CLSD (Clearside Biomedical)?
